Maria G. Ferrario
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Patient-reported outcome measures poorly correlate with objective inflammatory bowel disease activity measures: a systematic review.
Journal: Journal of Crohn's & colitis
Published: August 12, 2025
Quantifying Physician Preferences for Systemic Atopic Dermatitis Treatments Using a Discrete-Choice Experiment.
Journal: Dermatology and therapy
Published: March 04, 2022
Cost-effectiveness of Ruxolitinib vs Best Available Therapy in the Treatment of Myelofibrosis in Spain.
Journal: Journal of health economics and outcomes research
Published: November 29, 2017
Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain.
Journal: Journal of health economics and outcomes research
Published: January 28, 2016
Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: September 24, 2015
Liraglutide vs. sitagliptin add-on to metformin treatment for type 2 diabetes mellitus: Short-term cost-per-controlled patient in Italy.
Journal: Primary care diabetes
Published: June 01, 2015
Short-Term Cost-Effectiveness Analysis of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn (Nph) In Patients With Type 2 Diabetes Mellitus in Spain.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain
Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
Published: June 25, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026